Epidemiology, etiopathogenesis, and management of MRONJ: A European multicenter study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F24%3A10489222" target="_blank" >RIV/00179906:_____/24:10489222 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11150/24:10489222
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=TfE9_ddXmY" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=TfE9_ddXmY</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.jormas.2024.101931" target="_blank" >10.1016/j.jormas.2024.101931</a>
Alternative languages
Result language
angličtina
Original language name
Epidemiology, etiopathogenesis, and management of MRONJ: A European multicenter study
Original language description
Introduction: The purpose of this European multicenter study was to describe the general characteristics and risk factors of MRONJ lesions as well as their clinical diagnosis and management at different European Oral and Maxillofacial Surgery centers, in order to minimize selections biases and provide information about the epidemiology, etiopathogenesis, and the current trends in the treatment of MRONJ across Europe. Materials and methods: The following data were registered for each patient: gender; age at MRONJ diagnosis; past medical history; indication for antiresorptive or antiangiogenic therapy; type of antiresorptive medication; local risk factor for MRONJ; MRONJ Stage; anatomic location and symptoms; treatment; surgical complications; recurrence. Results: A total of 537 patients (375 females, 162 males) with MRONJ were included. Statistically significant associations were found between patients with metastatic bone disease and recurrences (P < 0.0005) and between advanced MRONJ stages (stages 2 and 3) and recurrences (P < 0.005). Statistically significant associations were also found between male gender and recurrences (P < 0.05), and between MRONJ maxillary sites and recurrences (P < 0.0000005). Conclusions: A longer mean duration of antiresorptive medications before MRONJ onset was observed in patients affected by osteoporosis, whereas a shorter mean duration was observed in all metastatic bone cancer patients, and in particular in those affected by prostate cancer with bone metastases or multiple myeloma. Surgery plays an important role for the management of MRONJ lesions. (c) 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, Al training, and similar technologies.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30208 - Dentistry, oral surgery and medicine
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Stomatology, Oral and Maxillofacial Surgery
ISSN
2468-8509
e-ISSN
2468-7855
Volume of the periodical
125
Issue of the periodical within the volume
5(Suppl. 1)
Country of publishing house
FR - FRANCE
Number of pages
7
Pages from-to
101931
UT code for WoS article
001325520800026
EID of the result in the Scopus database
2-s2.0-85195308392